Ramon Durazo-Arvizu, Ph.D. is a Professor of Public Health Sciences and has a strong background in mathematics and computer intensive statistical methods. He received his Ph.D. from the University of Arizona in Applied Mathematics, where he spent three years teaching mathematics and statistics courses. Additional teaching and research experience was gained through work at:
-The Arizona Cancer Center in Tucson, Arizona
-The University of Sonora, Hermosillo, Master’s program in Psychology and Business Administration
-The Mayo Clinic Cancer Center in Rochester, Minnesota
-The Medical University of South Carolina
-Northwestern University Medical School
-The Department of Public Health Sciences at Loyola University Medical Center where he serves as the head of the Biostatistics Division and co-director of the Master's Program in Clinical Research Methods
Dr. Durazo-Arvizu’s experience in applied statistics includes the analysis of time to an event data (Survival Analysis), multivariate linear and logistic regression, the genetics of hypertension, and the analysis of longitudinal data. In addition, he has gained extensive experience analyzing national data bases, including NHIS, NHANES, and has developed better models to explain the relationship between body mass index and mortality in blacks and whites after adjusting for relevant risk factors. In particular, he has combined existing statistical methods with newer computing techniques, such as bootstrapping and approximate randomization tests, to arrive at models that provide a better fit of the association between body mass index and all-cause mortality. Dr. Durazo-Arvizu has ample experience in statistical consulting with the different health sciences departments including Anesthesiology, Emergency Medicine, Pediatrics, Oncology, Endocrinology, Psychiatry (Alcohol and Drug Abuse Treatment), Rheumatology, Cardiology, Preventive Medicine, and others.
Dr. Durazo-Arvizu is an active member of the American Statistical Association. In 2000, he served as the program chair for the section in Epidemiology. He has organized sessions on Minority and Health and Diversity and the Risk of Cardiovascular Disease for the Association annual meetings and been appointed to the Committee of Minorities in Statistics (2003-2005, 2005-2008). He is also a member of the Eastern North American Region (ENAR) of the International Biometry Society for whom he moderated a workshop to discuss issues related to minority graduate students in Biostatistics. He is a member of the Society for the Advancement of Chicanos and Native Americans in Science (SACNAS).
Bisphenol A (BPA) Found in Humans and Water in Three Geographic Regions with Distinctly Different Levels of Economic Development. Karalius VP, Harbison JE, Plange-Rhule J, van Breemen RB, Li G, Huang K, Durazo-Arvizu RA, Mora N, Dugas LR, Vail L, Tuchman NC, Forrester T, Luke A. Environ Health Insights. 2014, 8:1-3.
Prediction of fat-free mass using bioelectrical impedance analysis in young adults from five populations of African origin. Luke A, Bovet P, Forrester TE, Lambert EV, Plange-Rhule J, Dugas LR, Durazo-Arvizu RA, Kroff J, Richie WN, Schoeller DA. Eur J Clin Nutr. 2013, 67:956-60.
Modeling a methylmalonic acid-derived change point for serum vitamin B-12 for adults in NHANES. Bailey RL, Durazo-Arvizu RA, Carmel R, Green R, Pfeiffer CM, Sempos CT, Carriquiry A, Yetley EA. Am J Clin Nutr. 2013, 98:460-7.
Lifestyle-related factors, obesity, and incident microalbuminuria: the CARDIA (Coronary Artery Risk Development in Young Adults) study. Chang A, Van Horn L, Jacobs DR Jr, Liu K, Muntner P, Newsome B, Shoham DA, Durazo-Arvizu R, Bibbins-Domingo K, Reis J, Kramer H. Am J Kidney Dis. 2013, 62:267-75.
25-hydroxyvitamin D levels in African American and Nigerian women. Durazo-Arvizu RA, Aloia JF, Dugas LR, Tayo BO, Shoham DA, Bertino AM, Yeh JK, Cooper RS, Luke A. Am J Hum Biol. 2013, 25:560-2.
Is there a reverse J-shaped association between 25-hydroxyvitamin D and all-cause mortality? Results from the U.S. nationally representative NHANES. Sempos CT, Durazo-Arvizu RA, Dawson-Hughes B, Yetley EA, Looker AC, Schleicher RL, Cao G, Burt V, Kramer H, Bailey RL, Dwyer JT, Zhang X, Gahche J, Coates PM, Picciano MF. J Clin Endocrinol Metab. 2013, 98:3001-9. .
Clinical inertia in poorly controlled elderly hypertensive patients: a cross-sectional study in Spanish physicians to ascertain reasons for not intensifying treatment. Gil-Guillén V, Orozco-Beltrán D, Carratalá-Munuera C, Márquez-Contreras E, Durazo-Arvizu R, Cooper R, Pertusa-Martínez S, Pita-Fernandez S, González-Segura D, Martin-de-Pablo JL, Pallarés V, Fernández A, Redón J. Am J Cardiovasc Drugs. 2013, 13:213-9.
Evaluation of Vitamin D Standardization Program protocols for standardizing serum 25-hydroxyvitamin D data: a case study of the program's potential for national nutrition and health surveys. Cashman KD, Kiely M, Kinsella M, Durazo-Arvizu RA, Tian L, Zhang Y, Lucey A, Flynn A, Gibney MJ, Vesper HW, Phinney KW, Coates PM, Picciano MF, Sempos CT. Am J Clin Nutr. 2013, 97:1235-42.
The effect of obesity on the relationship between serum parathyroid hormone and 25-hydroxyvitamin D in women. Shapses SA, Lee EJ, Sukumar D, Durazo-Arvizu R, Schneider SH. J Clin Endocrinol Metab. 2013, 98:E886-90.
The Nigerian antihypertensive adherence trial: a community-based randomized trial. Adeyemo A, Tayo BO, Luke A, Ogedegbe O, Durazo-Arvizu R, Cooper RS. J Hypertens. 2013, 31:201-7.
Impact of alternative approaches to assess outlying and influential observations on health care costs. Weichle T, Hynes DM, Durazo-Arvizu R, Tarlov E, Zhang Q. Springerplus. 2013, 2:614.
Reduced overall and event-free survival among colon cancer patients using dual system care. Tarlov E, Lee TA, Weichle TW, Durazo-Arvizu R, Zhang Q, Perrin R, Bentrem D, Hynes DM. Cancer Epidemiol Biomarkers Prev. 2012, 21:2231-41
Trends in mortality from myocardial infarction. A comparative study between Spain and the United States: 1990-2006. Orozco-Beltran D, Cooper RS, Gil-Guillen V, Bertomeu-Martinez V, Pita-Fernandez S, Durazo-Arvizu R, Carratala-Munuera C, Cea-Calvo L, Bertomeu-Gonzalez V, Seoane-Pillado T, Rosado LE. Rev Esp Cardiol (Engl Ed). 2012, 65:1079-85.
Hemoglobin levels triggering erythropoiesis-stimulating agent therapy in patients with cancer: the shift after United States Food and Drug Administration policy changes. Stroupe KT, Tarlov E, Lee TA, Weichle TW, Zhang QL, Michaelis LC, Ozer H, Durazo-Arvizu R, Browning MM, Hynes DM. Pharmacotherapy. 2012, 32:988-97.
A psychoeducational intervention (SWEEP) for depressed women with diabetes. Penckofer SM, Ferrans C, Mumby P, Byrn M, Emanuele MA, Harrison PR, Durazo-Arvizu RA, Lustman P. Ann Behav Med. 2012, 44:192-206.
Low vitamin D levels are associated with increased rejection and infections after lung transplantation. Lowery EM, Bemiss B, Cascino T, Durazo-Arvizu RA, Forsythe SM, Alex C, Laghi F, Love RB, Camacho P. J Heart Lung Transplant. 2012, 31:700-7.
Patterns of sodium and potassium excretion and blood pressure in the African Diaspora. Tayo BO, Luke A, McKenzie CA, Kramer H, Cao G, Durazo-Arvizu R, Forrester T, Adeyemo AA, Cooper RS. J Hum Hypertens. 2012, 26:315-24.
Changes in measurement procedure from a radioassay to a microbiologic assay necessitate adjustment of serum and RBC folate concentrations in the U.S. population from the NHANES 1988-2010. Pfeiffer CM, Hughes JP, Durazo-Arvizu RA, Lacher DA, Sempos CT, Zhang M, Yetley EA, Johnson CL.J Nutr. 2012, 142:894-900.
Effect of metformin therapy on vitamin D and vitamin B₁₂ levels in patients with type 2 diabetes mellitus. Kos E, Liszek MJ, Emanuele MA, Durazo-Arvizu R, Camacho P. Endocr Pract. 2012, 18:179-84.
Mortality rates across 25-hydroxyvitamin D (25[OH]D) levels among adults with and without estimated glomerular filtration rate <60 ml/min/1.73 m2: the third national health and nutrition examination survey. Kramer H, Sempos C, Cao G, Luke A, Shoham D, Cooper R, Durazo-Arvizu R. PLoS One. 2012, 7:e47458.
Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk. Luke A, Bovet P, Forrester TE, Lambert EV, Plange-Rhule J, Schoeller DA, Dugas LR, Durazo-Arvizu RA, Shoham D, Cooper RS, Brage S, Ekelund U, Steyn NP. BMC Public Health. 2011, 11:927.
Is there a predictive profile for clinical inertia in hypertensive patients? An observational, cross-sectional, multicenter study. Gil-Guillén V, Orozco-Beltrán D, Márquez-Contreras E, Durazo-Arvizu R, Cooper R, Pita-Fernández S, González-Segura D, Carratalá-Munuera C, Martín de Pablo JL, Pallarés V, Pertusa-Martínez S, Fernández A, Redón J. Drugs Aging. 2011,28:981-92.
Retinal arteriolar caliber and urine albumin excretion: the Multi-Ethnic Study of Atherosclerosis. Awua-Larbi S, Wong TY, Cotch MF, Durazo-Arvizu R, Jacobs DR Jr, Klein BE, Klein R, Lima J, Liu K, Kramer H. Nephrol Dial Transplant. 2011, 26:3523-8.
The effect of including cystatin C or creatinine in a cardiovascular risk model for asymptomatic individuals: the multi-ethnic study of atherosclerosis. Ito H, Pacold IV, Durazo-Arvizu R, Liu K, Shilipak MG, Goff DC Jr, Tracy RP, Kramer H. Am J Epidemiol. 2011, 174:949-57.